S T A T E O F N E W Y O R K
________________________________________________________________________
7789
2023-2024 Regular Sessions
I N A S S E M B L Y
June 15, 2023
___________
Introduced by M. of A. PAULIN -- read once and referred to the Committee
on Health
AN ACT to amend the public health law, in relation to establishing the
340B prescription drug anti-discrimination act
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Short title. This act shall be known and may be cited as
the "340B prescription drug anti-discrimination act".
§ 2. Declaration of purpose. Section 340B of the federal public health
service act requires pharmaceutical manufacturers, as a condition of
participation in Medicare and Medicaid, to provide discounts on outpa-
tient drugs to certain providers that serve a high number of Medicaid
patients. These cost savings enable safety-net providers to stretch
scarce resources as far as possible in providing more comprehensive
services to their communities.
In recent years, some pharmaceutical companies and pharmacy benefit
managers have imposed certain requirements and limitations on New York
340B covered entities, thus depriving such entities of much-needed cost
savings. These practices discriminate against 340B covered entities and
their pharmacy partners, and by extension the patients they serve. These
discriminatory practices have the effect of limiting those covered enti-
ties' ability to care for their communities fully and comprehensively.
There is a need for the state to prevent erosion of our 340B covered
entities' 340B cost savings, with its concomitant impacts on patient
access to health care services. This act is intended to achieve that
goal by prohibiting pharmaceutical companies, among other entities, from
engaging in practices that discriminate against 340B covered entities
and their pharmacy partners.
§ 3. The public health law is amended by adding a new section 280-d to
read as follows:
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11664-01-3
A. 7789 2
§ 280-D. PRESCRIPTION DRUG DISCRIMINATION PROHIBITED. 1. DEFINITIONS.
(A) "340B PROGRAM" SHALL MEAN THE DRUG DISCOUNT PROGRAM AUTHORIZED BY
SECTION 340B OF THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. §
256B).
(B) "COVERED ENTITY" SHALL:
(I) HAVE THE SAME MEANING AS IS SET FORTH IN SECTION 340B(A)(4) OF THE
FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. § 256B);
(II) MEAN AN ENTITY AUTHORIZED TO PARTICIPATE IN THE 340B PROGRAM; AND
(III) INCLUDE NEW YORK STATE PHARMACIES THAT RECEIVE DRUGS PURCHASED
UNDER A CONTRACT PHARMACY ARRANGEMENT WITH A COVERED ENTITY.
(C) "DISPENSING" SHALL INCLUDE A PHARMACY'S ENTIRE DISTRIBUTION PROC-
ESS, INCLUDING THE ORDERING, PURCHASING, DELIVERING, RECEIPT, AND SALE
OF DRUGS, AND ANY OTHER ASPECT OF SUCH DISTRIBUTION PROCESS THAT AN
ENTITY MAY SEEK TO DENY, PROHIBIT, CONDITION, OR OTHERWISE LIMIT.
(D) "PHARMACY" SHALL HAVE THE SAME MEANING AS IS SET FORTH IN SECTION
SIXTY-EIGHT HUNDRED TWO OF THE EDUCATION LAW.
2. PROHIBITION OF DISCRIMINATORY PRACTICE. NO ENTITY, INCLUDING BUT
NOT LIMITED TO A PHARMACEUTICAL MANUFACTURER OR PHARMACY BENEFIT MANAG-
ER, SHALL:
(A) DENY, PROHIBIT, CONDITION, OR OTHERWISE LIMIT THE DISPENSING OF
DRUGS FROM A COVERED ENTITY;
(B) DENY ACCESS TO DRUGS MANUFACTURED BY A PHARMACEUTICAL MANUFACTURER
TO A COVERED ENTITY BASED ON SUCH COVERED ENTITY'S PARTICIPATION IN THE
340B PROGRAM;
(C) IMPOSE REQUIREMENTS, EXCLUSIONS, REIMBURSEMENT TERMS, FEES,
AUDITS, CLAIM IDENTIFICATION, OR OTHER CONDITIONS ON A COVERED ENTITY
THAT DIFFER FROM THE REQUIREMENTS, EXCLUSIONS, REIMBURSEMENT TERMS,
FEES, AUDITS, CLAIM IDENTIFICATION, OR OTHER CONDITIONS APPLIED TO ENTI-
TIES THAT DO NOT PARTICIPATE IN THE 340B PROGRAM.
3. ENFORCEMENT. (A) ANY PROVISION OF A CONTRACT THAT IS CONTRARY TO
THIS ACT SHALL BE VOID AND UNENFORCEABLE.
(B) THE COMMISSIONER SHALL HAVE THE AUTHORITY TO IMPOSE A CIVIL MONE-
TARY PENALTY PURSUANT TO SECTION TWELVE OF THIS CHAPTER ON ANY ENTITY
THAT VIOLATES THE PROVISIONS OF THIS ACT.
(C) THE COMMISSIONER SHALL REFER ANY MATTERS IN WHICH A CIVIL MONETARY
PENALTY IS BEING IMPOSED TO THE EDUCATION DEPARTMENT AND THE OFFICE OF
THE ATTORNEY GENERAL FOR REVIEW.
§ 4. This act shall take effect immediately.